Get started
Author

Toshihiro Osada

Observed names: T. Osada, Toshihiro OSADA
Observed institutions: Kurume University, Henry Ford Health, Keio University, Taiho Pharmaceutical (Japan), Taiho Oncology (United States), Duke Medical Center
ORCID: 0000-0001-8331-9655
Observed ORCID: 0000-0001-8331-9655
OpenAlex ID: A5046553937
Inhibition of RANKL-Induced Osteoclastogenesis by (−)-DHMEQ, a Novel NF-κB Inhibitor, Through Downregulation of NFATc1
2005 · Hiroshi Takatsuna, Masataka Asagiri, et al. · Journal of Bone and Mineral Research · 154
PDF
Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment
2021 · Toshihiro Osada, Mitsuhiro Okano · Allergology International · 48
TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice
2020 · Yuki Tanaka, Hiroshi Wada, et al. · Scientific Reports · 22
PDF
Identification and gene cloning of a new major allergen Cha o 3 from Chamaecyparis obtusa (Japanese cypress) pollen
2016 · Toshihiro Osada, Takafumi Harada, et al. · Journal of Allergy and Clinical Immunology · 21
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
2016 · Casey Ager, Matthew Reilley, et al. · Journal for ImmunoTherapy of Cancer · 17
PDF
Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar–specific ASIT
2018 · Toshihiro Osada, Yuki Tanaka, et al. · Allergology International · 12
PDF
Glycoform of a newly identified pollen allergen, Cha o 3, from Chamaecyparis obtusa (Japanese cypress, Hinoki)
2017 · Toshihiro Osada, Megumi Maeda, et al. · Carbohydrate Research · 12
PDF
Generation of a Novel HLA Class I Transgenic Mouse Model Carrying a Knock-in Mutation at the β2-Microglobulin Locus
2016 · Naomoto Harada, Satoshi Fukaya, et al. · The Journal of Immunology · 12
Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis
2019 · Hirotaka Kikuoka, Hideaki Kouzaki, et al. · Clinical Immunology · 9
Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design
2018 · Hiroshi Wada, Atsushi Shimizu, et al. · PLoS ONE · 4
PDF
Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy
2023 · Toshihiro Shibutani, Risa Goto, et al. · Scientific Reports · 3
PDF
Correction: Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design
2018 · Hiroshi Wada, Atsushi Shimizu, et al. · PLoS ONE · 3
PDF
Identification of dominant T-cell epitopes in the major Japanese cypress pollen allergen Cha o 3
2019 · Toshihiro Osada, Akira Yamada, et al. · Allergology International · 2
PDF
Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells.
2010 · M. Morse, A. Hobeika, et al. · Journal of Clinical Oncology · 2
Author Correction: Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy
2024 · Toshihiro Shibutani, Risa Goto, et al. · Scientific Reports · 1
PDF
Author Correction: TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice
2022 · Yuki Tanaka, Hiroshi Wada, et al. · Scientific Reports · 1
PDF
Novel information regarding the allergens of Japanese cypress pollen
2018 · Toshihiro Osada · 耳鼻咽喉科免疫アレルギー · 1
PDF
ヒノキ花粉症発症に関する新知見: ヒノキ花粉主要アレルゲンCha o 3の同定とその特徴
2017 · Toshihiro OSADA · KAGAKU TO SEIBUTSU
PDF
Antigen presenting cell (APC)-targeted hCGβ vaccine for cancer therapy
2007 · M. Morse, R. Chapman, et al. · Journal of Clinical Oncology
Works count: 19
Citation count: 324
H-index: 9
I10-index: 8
Year
Topic
Type